Actinium Pharmaceuticals ... (ATNM)
AMEX: ATNM
· Real-Time Price · USD
1.53
-0.02 (-1.29%)
At close: May 13, 2025, 3:59 PM
1.47
-3.92%
After-hours: May 13, 2025, 07:55 PM EDT
-1.29% (1D)
| Bid | 1.47 |
| Market Cap | 47.73M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -38.24M |
| EPS (ttm) | -1.27 |
| PE Ratio (ttm) | -1.2 |
| Forward PE | -1.47 |
| Analyst | Buy |
| Ask | 1.53 |
| Volume | 169,147 |
| Avg. Volume (20D) | 648,631 |
| Open | 1.54 |
| Previous Close | 1.55 |
| Day's Range | 1.45 - 1.56 |
| 52-Week Range | 1.03 - 10.24 |
| Beta | -0.23 |
About ATNM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ATNM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ATNM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+18.35%
Actinium Pharmaceuticals shares are trading higher...
Unlock content with
Pro Subscription
1 month ago
+16.53%
Actinium Pharmaceuticals shares are trading higher after the company announced it entered a research collaboration with Memorial Sloan Kettering for clinical expansion of Actimab-A's backbone therapy strategy.
